A Clayman Thyroid Center report aims to clarify FDA safety warnings, finding no evidence that GLP-1 drugs like Ozempic cause common thyroid cancers. Current human data do not show a link between GLP-1 ...
A new white paper issued by the Clayman Thyroid Center in Tampa, Florida, concludes that popular GLP-1 receptor agonists ...
(NewsNation) — A popular thyroid drug could be associated with bone loss according to a new study from the Radiological Society of North America (RSNA). Levothyroxine, commercially known as Synthroid ...
NEW HAVEN, Conn. (WTNH) — In today’s Health Headlines, we’re talking about thyroid health — including how GLP-1 weight loss ...
Antiepileptic drugs (AEDs) form an essential component in the management of epilepsy; however, their long‐term use has been associated with alterations in thyroid function. These medications may ...
An unusual about-face that played out at the Food and Drug Administration over the last week illustrated the power of the “Make America Healthy Again” movement, particularly with its focus on “natural ...
The leading prescription medicine for hypothyroidism, taken by millions of Americans, has been plagued by problems that could harm the health of those who take it, according to the Food and Drug ...
W A S H I N G T O N, July 12 -- The government has advised makers of somewidely used thyroid drugs that they will have to begin cutting backdistribution of any that haven't won agency approval by Aug.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results